Back to Search
Start Over
What Surveillance Plan Should Be Advised for Patients in Remission After Completion of First-Line Therapy for Advanced Ovarian Cancer?
- Source :
- International Journal of Gynecological Cancer; 2010 Supplement 1, Vol. 20, pS27-S28, 2p
- Publication Year :
- 2010
-
Abstract
- Based on the results of the Medical Research Council OVO5/European Organisation for Research and Treatment of Cancer 55955 trial, the follow-up plan I recommend for patients in remission after completion of first-line therapy for advanced ovarian cancer is appointments: every 3 months for 2 years, every 4 months on the third year, then every 6 months thereafter, and discharge if no relapse by 10 years. History and examination (not internal) should be performed at each appointment. CA-125 should only be measured if there is a suspicion of relapse or at patient's request. No scans should be performed unless clinical indication or rising CA-125. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 1048891X
- Volume :
- 20
- Database :
- Supplemental Index
- Journal :
- International Journal of Gynecological Cancer
- Publication Type :
- Academic Journal
- Accession number :
- 113078640
- Full Text :
- https://doi.org/10.1111/IGC.0b013e3181f63a28